Composition
>
of 1 tablet contains:
Levonorgestrel 125 mcg and ethinyl estradiol 30 mcg
Pharmacological action
Minisiston has an estrogen-progestogenic, contraceptive effect.
Levonorgestrel in combination with ethinyl estradiol blocks the release of releasing factors (luteinizing and follicle-stimulating) of the hypothalamus, inhibits the secretion of gonadotropic hormones by the pituitary gland, and thus inhibits ovulation; increases the viscosity of mucus in the cervix, which makes it difficult for sperm to enter the uterine cavity.
When taken regularly, it normalizes the menstrual cycle and helps prevent a number of gynecological diseases, including those of a tumor nature.
Indications
Contraception, functional disorders of the menstrual cycle, dysmenorrhea.
Use during pregnancy and lactation
Contraindicated in pregnancy.
Contraindications
- Hypersensitivity,
- pregnancy,
- hormone-dependent tumors of the mammary glands or uterus,
- severe functional disorders and liver tumors,
- diabetes mellitus with vascular complications,
- thromboembolic diseases (including in the anamnesis),
- arterial and venous thrombosis,
- arterial hypertension (severe form).
Side effects
In rare cases, headache, depression, nausea, diarrhea, breast tenderness;
with prolonged use, very rarely — chloasma, deterioration of contact lens tolerance.
How to take, course of use and dosage
Minisiston is taken orally. For contraception — 1 tablet per day (the interval between the next doses should not exceed 36 hours) for 21 days, then — a 7-day break and a new cycle.
For functional disorders, the dose is selected by the doctor.
Special instructions
Use with caution in patients with varicose veins, phlebitis, multiple sclerosis, epilepsy, endometriosis, and liver diseases.
Treatment should be discontinued and a doctor should be consulted if migraine-like headaches, acute visual disturbances, pregnancy, acute thrombosis, bile congestion or jaundice, or a significant increase in blood pressure occur for the first time.
Form of production
Dragees
Storage conditions
In a dark place, at a temperature not exceeding 25°C.
Shelf
life is 5 years.
Active ingredient
Ethinyl Estradiol, Levonorgestrel
Conditions of release from pharmacies
By prescription
Dosage form
dragees
Description
For adults as prescribed by a doctor, For women of childbearing age
Indications
Contraception
Best price for Minizistone 20 FEM pills, drags, 21pcs in our online pharmacy!
Side effects of Minizistone 20 FEM pills, drags, 21pcs.
Reviews
There are no reviews yet